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Abstract
Prevention of canine heartworm disease caused by Dirofilaria immitis relies on chemopro-
phylaxis with macrocyclic lactone anthelmintics. Alarmingly, there are increased reports of
D. immitis isolates with resistance to macrocyclic lactones and the ability to break through
prophylaxis. Yet, there is not a well-established laboratory assay that can utilize biochemical
phenotypes of microfilariae to predict drug resistance status. In this study we evaluated lab-
oratory assays measuring cell permeability, metabolism, and P-glycoprotein-mediated
efflux. Our assays revealed that trypan blue, propidium iodide staining, and resazurin
metabolism could detect differences among D. immitis isolates but none of these
approaches could accurately predict drug susceptibility status for all resistant isolates
tested. P-glycoprotein assays suggested that the repertoire of P-gp expression is likely to
vary among isolates, and investigation of pharmacological differences among different P-gp
genes is warranted. Further research is needed to investigate and optimize laboratory
assays for D. immitis microfilariae, and caution should be applied when adapting cell death
assays to drug screening studies for nematode parasites.
Introduction
Dirofilaria immitis is the causative agent of canine heartworm disease, which is capable of
causing debilitating cardiovascular and respiratory signs in domestic dogs, cats, wild canids,
and mustelids including ferrets. Control and prevention of D. immitis largely relies on macro-
cyclic lactone (ML) chemoprophylaxis. This strategy prevents the development of adults from
3rd stage larvae of D. immitis following infection by L3s from mosquito intermediate hosts.
Remarkably, this approach has been largely successful for decades in the United States. Over
the past ten years, numerous lack of efficacy (LOE) reports have been made by veterinary
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practitioners [1–3]. This is certainly an alarming development. Subsequently, ML resistance in
D. immitis has been confirmed by establishing infections in dogs despite strict ML prophylaxis
under controlled conditions [3].
The detection of bona fide ML resistance in D. immitis infected animals is a major clinical
challenge. The only patient-side test that can predict drug resistance is the microfilaria sup-
pression test which involves measuring the number of microfilariae in blood before and after
ML treatment [4,5]. Laboratory-based larval migration inhibition assays measuring the ability
of L3 to migrate through a fine mesh in the presence of drugs have also been described [6,7].
However, motility measurements are not capable of differentiating between resistant and sus-
ceptible strains [7,8]. Microsatellite-based genetic assays are being currently evaluated to iden-
tify resistant isolates of D. immitis from clinical samples, but are time-consuming and
expensive [9]. However, no laboratory tests are available for determining drug susceptibility
status of D. immitis obtained from clinical specimens such as canine blood. Thus, there is a
need to develop laboratory assays that can be used to quickly and accurately detect ML resis-
tance. Ideally, such an assay would utilize microfilariae from the peripheral blood of infected
dogs and would be able to compare strain susceptibilities in vitro.
Laboratory assays that detect nematode mortality have been applied inconsistently among
different clades of nematodes. For example, cessation of motility is often used to measure nem-
atode death in basic science or drug screening studies [10]. Yet, there are many examples of
parasites that continue to be motile despite being subjected to concentrations of drugs that are
well above those reached in the tissues of a treated animal [8]. At the same time, our lab and
others have noted that some nematodes lack obvious movement, but are still alive, often
resuming motility following light or heat stimuli [11]. In addition, many drug discovery stud-
ies employ methods developed for detecting death in eukaryotic cell cultures without a clear
acceptance of any particular method. Years of research have evaluated numerous drug suscep-
tibility assays such as the larval motility inhibition test, the larval development test, the egg
hatch assay and others [12–14]. Yet, there is not a single accepted laboratory assay for detec-
tion of resistance in nematodes. Both investigators seeking “death phenotypes” in drug devel-
opment studies and clinicians facing treatment decisions would benefit from an improved
method for detecting and quantifying drug resistance.
Spectrophotometric, colorimetric, densitometric and image-based assays have been used to
evaluate helminth viability during in vitro drug studies [15,16]. Yet, from a clinical point of
view, no standard method is available for quantification of drug resistance across nematode
taxa. In contrast, minimum inhibitory concentrations are widely used to provide a standard-
ized measure of antimicrobial resistance in bacteria [17]. For D. immitis, it is not clear what in
vitro assays can be useful predictors of clinical drug susceptibility. Herein, we evaluate bio-
chemical methods relying on membrane permeability, metabolic activity, and P-gp activity as
surrogate phenotypic measures of ML susceptibility. These assays were selected as they could
possibly be adapted to a wide range of clinical settings with access to a spectrophotometric
plate reader. In this study, we hypothesized that these biochemical assays could differentiate
between microfilariae from different D. immitis strains bearing a known drug susceptibility
status. To test this hypothesis, we co-incubated microfilariae with different MLs and subjected
them to common assays used to detect cell death.
Materials and methods
Ethics
The experiments performed for this study received research approval from Iowa State Univer-
sity protocol IBC-19-008.
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Parasites
Heparinized dog blood with live D. immitis microfilariae, strain Missouri (ML-susceptible,
NR-48907) and strain JYD-27 (ML-resistant, NR-49172) were obtained from the NIH/NIAID
Filariasis Research Reagent Resource Center. The Missouri isolate was originally isolated in
2000 and has been maintained without ML preventatives [18]. Heparinized blood from dogs
experimentally infected with the ML-resistant strains Metairie and Yazoo were obtained from
the University of Georgia [8].
All assays were carried out within 72 hours of receiving the blood samples. Microfilariae
were isolated from the blood using a protocol modified from [11]. Briefly, 1 mL of blood was
added to 10 mL of filter-sterilized 0.2% saponin in MilliQ water, incubated in a 37˚C water
bath for 15 min and centrifuged at 350 x g for 5 min at room temperature. The supernatant
was removed and the microfilariae in the pellet were washed twice with 1x Dulbecco’s phos-
phate buffered saline. The pellet was resuspended in pre-warmed sterile 1x RPMI 1640 without
antibiotics. Microfilariae in the suspension were enumerated in three 10 μL aliquots for each
sample and used the same day.
Assay design
Assays were performed in 96-well flat-bottomed plates (Corning). Microfilariae of each isolate
were simultaneously tested on each plate whenever possible. Each test drug dilution had tech-
nical duplicates for each isolate and each well contained 300 total microfilariae with or without
dilutions of MLs in a total volume of 200 μL. ML solutions were made by diluting drugs in
0.1% DMSO. Every plate had 3 technical replicates of three experimental controls: (1) 300
microfilariae killed in a heat block at 95˚C for 1 min, (2) 300 live microfilariae with no drugs
and (3) 300 microfilariae with drug vehicle (0.1% DMSO) only. To determine background val-
ues for each assay, each plate also had 6 wells containing only assay reagents with no parasites.
For drug susceptibility experiments, each well contained 300 microfilariae co-incubated with
dilutions of MLs in RPMI1640 at 37˚C with 5% CO2 for 1 hr, followed by specific assays
described below. Experiments were typically first conducted with Missouri and JYD-27 isolates
due to availability and then investigated further with all four isolates. In the case of MTS and
ATP assays, further investigation with all four isolates was not pursued.
Trypan blue assay
To optimize the trypan blue assay, dilutions of the dye were incubated with different numbers
of live microfilariae, incubated for 3 min at room temperature and absorbance measured at
590 nm with a spectrophotometer (M2 Spectramax). For drug susceptibility assays, 20 μL of
0.4% trypan blue solution in 1x Dulbecco’s PBS was added to each well and the plate was incu-
bated for 3 min at room temperature followed by absorbance measurement in a spectropho-
tometer at 590 nm. Trypan blue assays were conducted four times with technical duplicates of
test wells and technical triplicates of controls.
Propidium iodide assay
Following ML incubation, 10 μL of 1 mg/mL aqueous solution of propidium iodide (Alfa
Aesar) was added to each well and the plate was incubated at 37˚C with 5% CO2 for 15 min.
Fluorescence from each well was measured in a spectrophotometer at excitation wavelength of
535 nm and emission wavelength of 617 nm. The assay was conducted three times, with tech-
nical duplicates of test wells and technical triplicates of control wells.
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Resazurin- resorufin assay
As a measure of metabolism, resazurin reduction assays were performed whereby resazurin is
metabolized to fluorescent resorufin. 20 μL of resazurin solution (CellTiterBlue, Promega) was
added to each well and the plate was incubated at 37˚C with 5% CO2 for 1 hr. Fluorescence of
the reduced product resorufin was measured in a spectrophotometer at excitation wavelength
of 579 nm and emission wavelength of 584 nm. The assay was conducted three times, with
technical duplicates of test wells and technical triplicates of control wells.
MTS tetrazolium assay
MTS assays were conducted with the colorimetric reagent—MTS tetrazolium in the presence
of phenazine methosulfate (PMS). 20 μL of combined MTS/PMS solution (CellTiter96, Pro-
mega) was added to each well and the plate was incubated at 37˚C with 5% CO2 for 1 hr.
Absorbance of soluble formazan bio-reduced from MTS was measured in a spectrophotometer
at 490 nm wavelength. The assay was conducted three times, with technical duplicates of test
wells and technical triplicates of control wells.
ATP luciferase assay
ATP production was measured using a commercial luciferase assay (CellTiterGlo, Promega).
Following ML incubation, microfilariae were washed with 1x Dulbecco’s PBS, lysed with 0.5
mm beads (Zymo Bashing Beads) in a bead beater for 5 min, centrifuged for 5 min at 1600 x g,
and 100 μL of lysate supernatant transferred to opaque walled 96 well plates. Incubation with
lysis buffer in the kit failed to lyse microfilariae. 100 μL of the recombinant luciferase reagent
was added to each well and the plate was incubated at room temperature for 30 min.”Glow
type” luminescence resulting from the interaction of ATP with luciferase was measured in a
spectrophotometer with 30 luminescent reads integrated over 5–10 min to obtain the final
value. ATP was serially diluted to make a standard curve.
Rhodamine 123 assay
ATP binding cassette B1 transporter (P-glycoprotein) activity was measured by incubating
microfilariae with the fluorescent P-glycoprotein substrate rhodamine 123 (R123) (AnaSpec).
20 μL of 20 μM R123 diluted in 1x Dulbecco’s PBS was added to each well and the plate was
incubated at 37˚C with 5% CO2 for 1 hr. Fluorescence from each well was measured in a spec-
trophotometer at excitation wavelength of 488 nm and emission wavelength of 530 nm.
Hoechst 33342 assay
To further assess the efflux function of P-gp transporters in microfilariae, the fluorescent P-
glycoprotein substrate Hoechst 33342 was co-incubated with the macrocyclic lactones and
microfilariae. Dilutions of macrocyclic lactones were incubated with 300 microfilariae per well
in RPMI1640 at 37˚C with 5% CO2 for 90 min. 20 μL of 20 μM Hoechst 33342 (ThermoScien-
tific) in 1x Dulbecco’s PBS was added to each well and the plate was incubated for 10 min at
room temperature. Fluorescence from each well was measured in a spectrophotometer at exci-
tation wavelength of 361 nm and emission wavelength of 486 nm.
Statistical analysis
One-way or two-way ANOVAs were performed to analyze absorbance, fluorescence and lumi-
nescence values obtained as assay outputs. A tukey test was used to compare the means of
groups. All statistical analyses were performed on GraphPad Prism 8.
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Results
Cell membrane integrity assays
Trypan blue staining is higher in Missouri isolate compared to resistant isolates. Try-
pan blue is commonly used to detect and selectively stain dead cells that have damaged mem-
branes [16]. The polysulphated hydrocarbon dye- trypan blue enters a cell upon membrane
damage and has previously been used to stain anatomic components of nematodes [16,19].
We found a linear relationship between absorbance and number of stained microfilariae with-
out removing excess dye (S1 Fig); this indicated measurement of intracellular proteins com-
plexed with trypan blue. In the presence of MLs, the susceptible Missouri isolate had higher
absorbance values when compared to ML-resistant isolates JYD-27, Metairie and Yazoo
(p< 0.05, Fig 1). A similar trend was observed in untreated microfilariae, although the differ-
ence between drug susceptible and resistant isolates was not as large as that observed in the
presence of MLs. While trypan blue staining had a dose-dependent relationship with ML treat-
ment, the apparent EC50 was similar for all isolates tested (S2 Fig).
Propidium iodide staining is elevated in Yazoo isolate in the presence of MLs. Propi-
dium iodide is another stain that is used to identify cells that have permeable membranes [16].
Propidium iodide is a nucleic acid intercalating agent that is also excluded from viable cells.
Following intercalation, the excitation/emission maxima change, allowing for the specific mea-
surement of intracellular staining. In some studies, C. elegans viability has been assessed using
this method [20,21]. In our assays, there were no significant differences among D. immitis iso-
lates for fluorescence values when live microfilariae were incubated with propidium iodide in
the absence of MLs (Fig 2). Under a range of ivermectin concentrations, the resistant isolate
Yazoo had significantly increased fluorescence values compared to the other isolates, with the
most pronounced difference observed at 100μM (p< 0.05, Fig 2).
There were no significant differences in pairwise comparisons of fluorescence when sela-
mectin was used except that Yazoo was higher than Metairie at 5μM concentration (p = 0.016).
For milbemycin oxime, there were no significant differences in pairwise comparisons except
Yazoo was higher than Metairie at 10μM concentration (p = 0.0329). Typical sigmoid dose-
response curves were not observed over the range of drug concentrations tested (Fig 2, S3 Fig).
Metabolism assays
Missouri isolate has higher metabolic activity as measured by resazurin metabolism.
The metabolism assays used in this study, Resazurin (Alamar blue) and MTS, are dyes that
allow the measurement of cellular redox activity. Non-fluorescent resazurin is reduced to fluo-
rescent resorufin as early as 1 hour in helminth studies [22]. Investigators have used the reduc-
tion of resazurin to resorufin as a measure of metabolism for cell viability assays and as an
alternative to motility [23]. In the present study, the different isolates exhibited large variation
in resazurin metabolism in the absence of MLs, with the drug- susceptible Missouri isolate
having significantly higher values when compared to the resistant isolates JYD-27 or Metairie
(Fig 3). The pattern of resorufin metabolism was consistent in the presence of 1μM MLs, with
Missouri having significantly higher values than JYD-27 and Metairie (Fig 3). Yazoo microfi-
lariae reduced resazurin less than Missouri microfilariae, but more than JYD-27 and Metairie
microfilariae (Fig 3). However, these differences were not statistically significant. A similar
pattern of resazurin metabolism was observed in the presence of MLs. Concentration of MLs
did not have a dose-dependent relationship with resazurin metabolism (S4 Fig).
MTS Tetrazolium assay is not suitable for distinguishing differences among strains.
MTS tetrazolium in the presence of phenazine methosulfate is a modified MTT assay, in
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Fig 1. Trypan blue staining. Absorbance values (mean ± SE) obtained by incubating trypan blue and microfilariae after
incubation with no drugs, 1μM of ivermectin, 1μM of selamectin and 1μM of milbemycin oxime for 1 hr at 37˚C.
(Asterisks indicate differences between strains at a given drug dose, � p< 0.05, �� p< 0.01, ��� p< 0.001).
https://doi.org/10.1371/journal.pone.0237150.g001
Fig 2. Propidium iodide staining. Fluorescence values (mean ± SE) obtained by incubating propidium iodide and microfilariae after
pre-incubation with no drugs or ivermectin for 1 hr at 37˚C. (Asterisks indicate differences between strains at a given drug dose, �
p< 0.05, �� p< 0.01, ��� p< 0.001).
https://doi.org/10.1371/journal.pone.0237150.g002
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which the membrane-permeable tetrazolium salt is reduced to a dark water-soluble formazan
product by metabolically active cells which can be measured spectrophotometrically [24].
MTT has long been used in in vitro nematode viability assays [24,25]. Co-incubation with MLs
caused absorbance values to increase in a dose-dependent manner (S5 Fig), but no differences
were observed among isolates incubated with the MTS reagent in the absence of drugs (S5
Fig). Following this result, no further MTS assays were pursued.
Luciferase assay detects low levels of ATP after bead beating. Bioluminescence based
quantitative measurements of ATP have been used as indicators of nematode metabolism and
survival [26]. The amount of luminescence is directly proportional to the number of viable
cells present prior to reagent-induced cell lysis. Attempted uses of ATP/luciferase assays to
assess drug induced death in helminths suffer from the inability of the reagent to induce lysis
[27]. Initial investigation revealed that the ATP reagent used was unable to cause lysis of
microfilariae. However, bead beating was adequate to release cytoplasmic contents and the
supernatant could be used in the luciferase assay. A standard curve of luminescence values was
obtained with serial dilutions of ATP (R2 = 0.999) (S6 Fig). No significant differences in
Fig 3. Resazurin metabolism. Fluorescence values (mean ± SE) obtained by incubating resazurin and microfilariae after incubation with
no drugs, 1μM of ivermectin, 1μM of selamectin and 1μM of milbemycin oxime for 1 hr at 37˚C. (Asterisks indicate differences between
strains at a given drug dose, � p< 0.05, �� p< 0.01).
https://doi.org/10.1371/journal.pone.0237150.g003
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luminescence were observed between JYD-27 and Missouri isolates incubated with or without
MLs (Fig 4).
P-glycoprotein assays
R123 efflux activity is increased in Metairie and Yazoo isolates. Rhodamine 123 is a
fluorescent substrate that binds to the R site on P-gp and is effluxed by mammalian and nema-
tode P-gps [28]. In the absence of drugs, Metairie and Yazoo had increased P-gp activity indi-
cated by lower levels of intracellular R123 compared to the Missouri isolate (P<0.05, Fig 5).
However, P-gp mediated efflux activity of JYD-27 was indistinguishable from Missouri. Efflux
assays conducted in the presence of MLs revealed no differences among isolates, and fluores-
cence values did not have a dose-response relationship with the MLs (S7 Fig).
H33342 efflux activity is decreased in Yazoo isolate. Hoechst 33342 is a fluorescent sub-
strate that binds to the H site on P-gp and is effluxed by mammalian and nematode P-gp [28].
Constitutive P-gp-mediated H33342 efflux activity was higher in Missouri, JYD-27, and Met-
airie, with reduced P-gp activity in Yazoo (Fig 6). Co-incubation with MLs reduced the
amount of P-gp activity in a dose-dependent manner, with P-gp activity that was lower in the
Missouri isolate at high doses of MLs (S8 Fig). Dose-response experiments were not performed
with Yazoo and Metairie for H33342 due to availability of sufficient microfilariae during the
study period.
Discussion
The incidence of dirofilariosis is increasing in the United States [29,30]. Concurrently, there is
a rise in the number of lack of efficacy (LOE) reports made by veterinarians [9]. The ability to
distinguish compliance failure and true ML resistance is a necessity, and using experimental
infections to determine ML susceptibility status is both difficult and undesirable. An in vitro
assay using microfilariae as a surrogate to measure ML susceptibility could provide useful
prognostic information to clinicians and harmonize basic drug discovery studies.
Fig 4. Recombinant luciferase assay. ATP concentrations (mean ± SE) obtained by interpolating from the standard
curve. Luminescence values used to calculate ATP concentrations were obtained by incubating luciferase with
microfilariae with dilutions of macrocyclic lactones drugs for 1 hr at 37˚C.
https://doi.org/10.1371/journal.pone.0237150.g004
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Our experiments revealed that several assays could detect isolate-specific differences follow-
ing exposure to MLs, but that these differences were not always predictive of clinical suscepti-
bility status. For example, the susceptible isolate (Missouri) had increased trypan blue staining
Fig 5. R123 efflux assay. Fluorescence values (mean ± SE) obtained by incubating Rhodamine 123 and microfilariae
in media in the absence of drugs for 1 hr at 37˚C. (Asterisks indicate differences between strains p< 0.05).
https://doi.org/10.1371/journal.pone.0237150.g005
Fig 6. H3342 efflux assay. Fluorescence values (mean ± SE) obtained by incubating Hoechst 33342 and microfilariae
in media in the absence of drugs for 1 hr at 37˚C. (Asterisks indicate differences between strains p< 0.05).
https://doi.org/10.1371/journal.pone.0237150.g006
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PLOS ONE | https://doi.org/10.1371/journal.pone.0237150 August 6, 2020 9 / 14
as compared to the resistant isolates (JYD-27, Metairie, Yazoo) following exposure to 1μM
macrocyclic lactones. However, this trend was also present in the absence of MLs (Fig 1).
Unexpectedly, propidium iodide staining was increased in Yazoo compared to other isolates
in the presence of MLs. Significant differences in resazurin reduction in the absence of drugs
suggest that basal metabolic levels vary among isolates. The susceptible Missouri isolate had
higher basal metabolism and was able to reduce resazurin at higher levels than the resistant iso-
lates JYD-27 and Metairie, but not Yazoo. These patterns were similar in the presence of MLs
and were surprising since we expected the resistant isolates to have increased metabolism in
the presence of MLs. Taken together our data underscores the need to test a broad range of iso-
lates when investigating methods for detecting resistance. Clearly, some isolate-specific differ-
ences can be detected these methods are not capable of detecting all resistant isolates under the
conditions tested. However, it is quite possible that these assays could be further optimized
with different temperatures or drug exposure times, resulting in more definitive outcomes.
P-gps contribute to drug resistant phenotypes in several nematode parasites and have been
implicated in D. immitis resistance to MLs [18,31,32]. P-gps are transmembrane pumps that
efflux xenobiotics including MLs across membranes and are expressed in both the nematode
intestine and body wall [33,34]. R123 and H33342 are fluorescent substrates of P-gp and accu-
mulate in the mitochondria or nucleus, respectively, if they are not removed via P-gp mediated
efflux activity [35]. The two dyes bind to different sites on P-gp molecules [28,36]. Using R123,
we found that basal levels of P-gp efflux activity were higher in Metairie and Yazoo as com-
pared to Missouri. On the other hand, in the H33342 assays, there was increased P-gp activity
in Missouri, JYD-27, and Metairie. The different results with the two P-gp substrates may indi-
cate different repertoires of P-gp gene expression and substrate specificity, since there are
numerous P-gp genes expressed by D. immitis and the two substrates tested bind different sites
[37]. We hypothesize this finding indicates different profiles of P-gp expression or gene poly-
morphisms at R123 and/or H33342 binding sites [38,39]. Our findings were consistent with
previous studies of Haemonchus contortus where P-gp is up-regulated in some but not all resis-
tant isolates [40,41]. Whole organism P-gp assays are useful for understanding the net P-gp
activity in an organism, but the differences among isolates and assays suggests that individual
P-gps should also be studied in isolation to further understand pharmacological differences.
This study investigated membrane permeability, metabolic activity, and P-gp activity to
measure ML-mediated killing of microfilariae among different D. immitis isolates. In some
cases, assays could detect differences among resistant and susceptible isolates, but no single
test clearly discriminated all resistant and susceptible isolates. Interestingly, there were also dif-
ferences among the resistant isolates tested. These diverse phenotypes reinforce the impor-
tance of evaluating multiple isolates during drug screening if microfilariae are used. Our
results suggest that further optimization is needed before any of the tested assays could be used
to detect resistance in a clinical setting. In our studies, we only evaluated worms following 1 hr
of drug exposure for clinical convenience. It is likely that longer co-incubation times could
lead to more definitive phenotypic differences among isolates. Our results suggest there is a
need to explore the assays under a variety of conditions such as time or temperature.
Altogether, our studies suggest that phenotypic differences exist among isolates of D. immi-
tis, and this may confound the laboratory detection of resistance using methods developed for
detecting death in cell cultures. Importantly, investigators should be cautious when using such
assays in anti-parasitic drug screening, as they may not reveal the true “live” or “dead” status of
the parasite. Assessment of biochemical phenotypes of regional D. immitis populations under
refined conditions will be helpful for improvement of these assays. Such studies may also pro-
vide phenotypic clues leading to future hypothesis-driven discovery of ML drug resistance
mechanisms.
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S4 Fig. Resazurin metabolism. Fluorescence values (mean ± SE) obtained by incubating resa-
zurin and microfilariae after incubation with different dilutions of ivermectin, selamectin and
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S6 Fig. Recombinant luciferase optimization. Luminescence values obtained with a standard
curve of pure ATP. Non-linear fit, R2 = 0.9999.
(DOCX)
S7 Fig. Fluorescence values (mean ± SE) obtained by incubating Rhodamine123 and micro-
filariae after incubation with different dilutions of ivermectin, selamectin and milbemycin
oxime for 1 hour at 37˚C.
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S8 Fig. Fluorescence values (mean ± SE) obtained by incubating Hoechst33342 and micro-
filariae after incubation with different dilutions of ivermectin, selamectin and milbemycin
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